课题基金 / 基金详情

Critical effects associated with developmental PFAS exposure profiles

Critical effects associated with developmental PFAS exposure profiles
与发育 PFAS 接触情况相关的关键影响
批准号:
10704011
负责人:
PHILIPPE ADAM GRANDJEAN
金额:
$48.25万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
未结题
起止时间:
2017-09-01 至 2027-06-30
关键词:
14 year old5 year old9 year oldAchievementAdaptive Immune SystemAdultAdverse effectsAffectAgeAge MonthsAntibodiesAntibody FormationAntibody ResponseApolipoproteins CBiological MarkersBirthBloodBlood specimenBone Mineral ContentsBreast FeedingCOVID-19 severityChildChildhoodCholesterolClinicalClinical DataCohort StudiesCommunicable DiseasesComplementDataDependenceDevelopmentDual-Energy X-Ray AbsorptiometryEndocrineEndocrine disruptionEnvironmental PollutantsEquationEtiologyExposure toFaeroe IslandsFrequenciesGeneral PopulationGeneticGoalsHealthHumanHuman DevelopmentHuman MilkHuman Papilloma Virus VaccineImmuneImmune System DiseasesImmune systemImmunologic MarkersIncidenceInfectionInflammationInsulin-Like Growth Factor IJointsLactationLifeLinkLipidsLymphocyte CountMeasuresMetabolicMetabolic DiseasesModelingNon-Insulin-Dependent Diabetes MellitusObesityOsteoporosisOutcomePathogenesisPathway interactionsPatternPoly-fluoroalkyl substancesPrediabetes syndromePredispositionPregnancyPreventionProspective StudiesPubertyPublic HealthRegression AnalysisReportingResearchRiskRisk AssessmentRodentRoleSamplingScanningSerumSerum MarkersSignal Recognition ParticleSkinfold ThicknessSourceStatistical MethodsTimeToxoidsUmbilical Cord BloodVaccinationVaccinesadipokinesclinical examinationclinical phenotypeclinically relevantcohortearly life exposureenvironmental chemicalepidemiology studyimmune functionimmune system functionimmunotoxicityimprovedinfancyinflammatory markerinsightnext generationpostnatalprenatalprospectivesexual dimorphismvaccine failurevaccine-induced antibodies

项目摘要

项目成果

PHILIPPE ADAM GRANDJEAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT – PROJECT 2 CRITICAL EFFECTS Metabolic diseases, including obesity and type 2 diabetes, are major public health problems of multifactorial etiology, in which early-life exposures to environmental pollutants, such as per- and polyfluoroalkyl substances (PFAS), appear to play a role. In parallel, a critical effect of PFAS exposure is immunotoxicity that paves the way for immune dysfunction and infectious disease. STEEP Project 2 (P2–Critical Effects) will examine the role of developmental exposure profiles for these high-priority environmental pollutants and determine outcomes up to ages 5 and 14 years to allow identification of windows of susceptibility. We will rely on two birth cohorts from the Faroe Islands (total N >1000) to prospectively explore the associations between exposure profiles of PFAS and outcomes, including immune deficiencies (suboptimal antibody production after vaccinations, and increased frequency of infectious disease) and metabolic abnormalities (excess adiposity, hyperlipidaemia, low bone mineral content, and prediabetes). P2–Critical Effects will further evaluate the possible usefulness of clinically relevant biomarkers in serum (such as cholesterol subfractions, adipocytokines, insulin-like growth factor-1). Exposure data are already available from analyses of maternal pregnancy, cord blood and postnatal serum at ages 18 months, 5 and 9 years from the oldest Cohort 5, and clinical data, including DXA scans, are available for comparisons with age 14 years. The youngest Cohort 6 is currently being formed, with blood samples and human milk being taken during infancy for PFAS analyses that will allow determination of PFAS transfer from lactation. Multiple regression analyses with adjustment for other environmental chemicals will be complemented by structural equation models and other advanced statistical methods. Thus, the proposed study will aim at providing prevention potentials and new insights into the pathogenesis of major public health problems that are associated with early-life exposures to high-priority environmental pollutants.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Vulnerability During Infancy to Immunotoxic Contaminant Exposures
  • 批准号:
    10337281
  • 项目类别:
  • 资助金额:
    $53.18万
  • 财政年份:
    2020
  • 负责人:
    PHILIPPE ADAM GRANDJEAN
  • 依托单位:
Vulnerability During Infancy to Immunotoxic Contaminant Exposures
  • 批准号:
    9885685
  • 项目类别:
  • 资助金额:
    $53.85万
  • 财政年份:
    2020
  • 负责人:
    PHILIPPE ADAM GRANDJEAN
  • 依托单位:
Vulnerability During Infancy to Immunotoxic Contaminant Exposures
  • 批准号:
    10737655
  • 项目类别:
  • 资助金额:
    $36.49万
  • 财政年份:
    2020
  • 负责人:
    PHILIPPE ADAM GRANDJEAN
  • 依托单位:
Assessment of PFAS exposures and health effects in two Massachusetts communities with PFAS drinking water contamination
  • 批准号:
    10021527
  • 项目类别:
  • 资助金额:
    $100.0万
  • 财政年份:
    2019
  • 负责人:
    PHILIPPE ADAM GRANDJEAN
  • 依托单位:
海外基金